Studies Support Use of the Accuray TomoTherapy(R) System for Advanced Rectal Cancer to Improve Treatment Efficacy and Reduce Side Effects

SUNNYVALE, Calif., Feb. 5, 2020 -- (Healthcare Sales & Marketing Network) -- Accuray Incorporated (NASDAQ: ARAY) announced today that two new studies demonstrate the benefits of the TomoTherapy® System in the treatment of advanced rectal cancer. Radio... Devices, Oncology Accuray, radiotherapy, TomoTherapy, Radixact, rectal cancer
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news